What is the recommended duration of Bactroban (mupirocin) use for an infected wound?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Duration of Bactroban (Mupirocin) Use for Infected Wounds

Apply Bactroban cream to the infected wound three times daily for 10 days. 1

Standard Treatment Protocol

The FDA-approved dosing regimen is clear and straightforward:

  • Apply a small amount of Bactroban cream to the affected area 3 times daily for 10 days 1
  • The treated area may be covered with a gauze dressing if desired 1
  • Reassess patients who do not show clinical response within 3 to 5 days 1

Clinical Evidence Supporting This Duration

Multiple high-quality studies confirm the effectiveness of this 10-day treatment course:

  • A randomized controlled trial demonstrated that mupirocin cream applied topically 3 times daily for 10 days achieved 95.1% clinical success in treating secondarily infected wounds (small lacerations, abrasions, or sutured wounds), which was equivalent to oral cephalexin 2
  • The bacteriologic success rate was 96.9% with this regimen 2
  • Treatment duration of 4-10 days showed no difference in clinical outcomes, suggesting that the 10-day course provides optimal coverage without unnecessary prolongation 3

Shorter Duration for Specific Situations

In certain clinical contexts, shorter treatment courses of 5 days have proven effective:

  • For MRSA burn wound infections, 5 days of twice-daily mupirocin application eliminated MRSA in all treated wounds, with maximum therapeutic response seen within 4 days 4
  • However, this shorter duration should be reserved for selective use in burns less than 20% total body surface area 4

Important Clinical Caveats

Early reassessment is critical:

  • If no clinical improvement occurs within 3-5 days, reevaluate the patient for alternative diagnoses, resistant organisms, or need for systemic antibiotics 1
  • Mupirocin demonstrates minimal systemic absorption through intact skin, making it safe for the standard 10-day course 1

Resistance considerations:

  • Limit mupirocin use to the recommended duration to minimize development of high-level resistance 4
  • The drug should not be used prophylactically or for extended periods beyond what is clinically necessary 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.